Related Experiment Video
Updated: Aug 30, 2026

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
Receptor priming of major group human rhinoviruses for uncoating and entry at mild low-pH environments
Ghasem Nurani1, Birgitta Lindqvist, José M Casasnovas
1Karolinska Institute, Department of Biosciences at NOVUM, Center for Biotechnology, 141 57 Huddinge, Sweden.
Abstract:
Receptor priming of low-pH-triggered virus entry has been described for an enveloped virus (15). Here we show with major group human rhinoviruses (HRV) and its intercellular adhesion molecule-1 receptor that nonenveloped viruses follow this novel cell entry principle. In vitro the receptor primed HRV for efficient uncoating at mild low pH (5.5 to 6.0). Agents preventing endosomal acidification reduced or blocked rhinovirus cell infection, while nocodazole had no effect on infection of any serotype tested. The entry inhibitory effect of lysosomotropic agents was overcome by exposing cell-internalized HRV to mild low pH (5.5 to 6.0). We therefore conclude that receptor priming of major group HRV must occur in vivo as well. Cooperation of a cellular receptor and low pH in virus uncoating will polarize the exit of the genome to the receptor-bound, membrane-proximal region of the virus particle during acidification of endosomes. This process must be required for efficient penetration of the cellular membrane by viruses.
Insights
Nonenveloped human rhinoviruses (HRV) utilize receptor priming for low-pH-triggered cell entry, a mechanism previously seen only in enveloped viruses. This process facilitates efficient viral uncoating and genome release for infection.
Area of Science:
- Virology
- Cell Biology
- Molecular Biology
Background:
- Receptor priming for low-pH-triggered entry was known for enveloped viruses.
- The entry mechanism of nonenveloped viruses, like major group human rhinoviruses (HRV), was less understood.
- Intercellular adhesion molecule-1 (ICAM-1) is a known receptor for major group HRV.
Purpose of the Study:
- To investigate if nonenveloped viruses, specifically major group HRV, employ receptor priming for cell entry.
- To elucidate the role of low pH and receptor interactions in HRV uncoating and infection.
- To determine if HRV entry follows the novel cell entry principle observed in enveloped viruses.
Main Methods:
- In vitro experiments assessing HRV uncoating at varying pH levels.
- Cell infection assays using agents that affect endosomal acidification (lysosomotropic agents).
- Testing the effect of nocodazole on HRV infection.
- Exposure of internalized HRV to mild low pH to overcome entry inhibition.
Main Results:
- Receptor priming by ICAM-1 primed HRV for efficient uncoating at mild low pH (5.5-6.0).
- Inhibition of endosomal acidification reduced or blocked HRV infection.
- The inhibitory effect of lysosomotropic agents could be reversed by exposing internalized HRV to mild low pH.
- Nocodazole did not affect HRV infection across tested serotypes.
Conclusions:
- Major group HRV utilize receptor priming for entry, similar to enveloped viruses.
- Receptor-primed HRV uncoating at low pH is essential for efficient cell membrane penetration.
- This mechanism likely occurs in vivo, involving receptor-mediated genome release during endosomal acidification.
Related Concept Videos
Inhibitors Of Virion Release
Respiratory Syncytial Virus Disease
Bacteriophages of the Human Virome
Influenza
Viral Structure
Human Virome

